Scarica l'app Stockscreener
3.90
2.74%
-0.11
Dopo l'orario di chiusura:
3.90
Precedente Chiudi:
$4.01
Aprire:
$4.05
Volume 24 ore:
373.90K
Relative Volume:
3.13
Capitalizzazione di mercato:
$449.54M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-14.10%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.80
$4.08
Intervallo di 1 settimana:
$3.80
$4.71
Portata 52W:
$3.80
$5.14
Novabridge Biosciences Adr Stock (NBP) Company Profile
Nome
Novabridge Biosciences Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
3.90 | 462.22M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-03 | Iniziato | Leerink Partners | Outperform |
| 2025-09-09 | Iniziato | BTIG Research | Buy |
| 2021-12-09 | Iniziato | Siebert Williams Shank | Buy |
| 2021-06-02 | Iniziato | Daiwa Securities | Buy |
| 2021-03-15 | Iniziato | Needham | Buy |
| 2021-03-03 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-25 | Iniziato | Piper Sandler | Overweight |
| 2020-12-07 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-02-12 | Iniziato | China Renaissance | Buy |
| 2020-02-11 | Iniziato | Jefferies | Buy |
Mostra tutto
Novabridge Biosciences Adr Borsa (NBP) Ultime notizie
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Nigeria
NovaBridge subsidiary Visara appoints two key ophthalmology leaders - Investing.com India
NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward - GlobeNewswire Inc.
How does Talphera Inc (TLPH) change from a tortoise to a hare? - Setenews
This trade activity should not be overlooked: Zooz Strategy Ltd (ZOOZ) - setenews.com
There is no way NovaBridge Biosciences. ADR (NBP) can keep these numbers up - setenews.com
Prepare Yourself for Liftoff: Sandisk Corp (SNDK) - Setenews
NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz
NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz
NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz
Total equity of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
Equity in earnings of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
symbol__ Stock Quote Price and Forecast - CNN
NBP Forecast — Price Target — Prediction for 2026 - TradingView
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - Barchart.com
I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com
I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO By Investing.com - Investing.com South Africa
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Bank of New York Mellon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAcadian Asset Management (NYSE:AAMI), C3.ai (NYSE:AI) - Benzinga
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga
Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday - Benzinga
Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar
10 of the Cheapest Stocks of 2022 - Morningstar
The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar
New 5-Star Stocks - Morningstar
ORIC Stock Price | Oric Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
ADPT Stock Price | Adaptive Biotechnologies Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch
Novabridge Biosciences Adr Azioni (NBP) Dati Finanziari
Non sono disponibili dati finanziari per Novabridge Biosciences Adr (NBP). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.53%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):